Relevant bibliographies by topics / Tobacco use Treatment Victoria

Academic literature on the topic 'Tobacco use Treatment Victoria'

Author: Grafiati
Published: 10 December 2022
Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Tobacco use Treatment Victoria.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Tobacco use Treatment Victoria"

1

Jackson, Melissa A., Amanda L. Brown, Amanda L. Baker, Gillian S. Gould, and Adrian J. Dunlop. "The Incentives to Quit tobacco in Pregnancy (IQuiP) protocol: piloting a financial incentive-based smoking treatment for women attending substance use in pregnancy antenatal services." BMJ Open 9, no. 11 (November 2019): e032330. http://dx.doi.org/10.1136/bmjopen-2019-032330.

Full text
Abstract:
IntroductionWhile tobacco smoking prevalence is falling in many western societies, it remains elevated among high-priority cohorts. Rates up to 95% have been reported in women whose pregnancy is complicated by other substance use. In this group, the potential for poor pregnancy outcomes and adverse physical and neurobiological fetal development are elevated by tobacco smoking. Unfortunately, few targeted and effective tobacco dependence treatments exist to assist cessation in this population. The study will trial an evidence-based, multicomponent tobacco smoking treatment tailored to pregnant women who use other substances. The intervention comprises financial incentives for biochemically verified abstinence, psychotherapy delivered by drug and alcohol counsellors, and nicotine replacement therapy. It will be piloted at three government-based, primary healthcare facilities in New South Wales (NSW) and Victoria, Australia. The study will assess the feasibility and acceptability of the treatment when integrated into routine antenatal care offered by substance use in pregnancy antenatal services.Methods and analysisThe study will use a single-arm design with pre–post comparisons. One hundred clients will be recruited from antenatal clinics with a substance use in pregnancy service. Women must be <33 weeks’ gestation, ≥16 years old and a current tobacco smoker. The primary outcomes are feasibility, assessed by recruitment and retention and the acceptability of addressing smoking among this population. Secondary outcomes include changes in smoking behaviours, the comparison of adverse maternal outcomes and neonatal characteristics to those of a historical control group, and a cost-consequence analysis of the intervention implementation.Ethics and disseminationProtocol approval was granted by Hunter New England Human Research Ethics Committee (Reference 17/04/12/4.05), with additional ethical approval sought from the Aboriginal Health and Medical Research Council of NSW (Reference 1249/17). Findings will be disseminated via academic conferences, peer-reviewed publications and social media.Trial registration numberAustralia New Zealand Clinical Trial Registry (Ref: ACTRN12618000576224).
APA, Harvard, Vancouver, ISO, and other styles
2

Guydish, Joseph, Kwinoja Kapiteni, Thao Le, Barbara Campbell, Erika Pinsker, and Kevin Delucchi. "Tobacco use and tobacco services in California substance use treatment programs." Drug and Alcohol Dependence 214 (September 2020): 108173. http://dx.doi.org/10.1016/j.drugalcdep.2020.108173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Leone, Frank T., Sarah Evers-Casey, Mary A. Mulholland, and David P. L. Sachs. "Integrating Tobacco Use Treatment Into Practice." Chest 149, no. 2 (February 2016): 568–75. http://dx.doi.org/10.1378/chest.15-0441.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rigotti, Nancy A. "Treatment of Tobacco Use and Dependence." New England Journal of Medicine 346, no. 7 (February 14, 2002): 506–12. http://dx.doi.org/10.1056/nejmcp012279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shelley, Donna, Deanna Jannat-Khah, and Mark Wolff. "Tobacco-use treatment in dental practice." Journal of the American Dental Association 142, no. 6 (June 2011): 592–96. http://dx.doi.org/10.14219/jada.archive.2011.0229.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kalkhoran, Sara, Neal L. Benowitz, and Nancy A. Rigotti. "Prevention and Treatment of Tobacco Use." Journal of the American College of Cardiology 72, no. 9 (August 2018): 1030–45. http://dx.doi.org/10.1016/j.jacc.2018.06.036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Miranda, John. "Tobacco use in the treatment trenches." Alcoholism & Drug Abuse Weekly 32, no. 17 (April 24, 2020): 5–6. http://dx.doi.org/10.1002/adaw.32702.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

McCuistian, Caravella, Kwinoja Kapiteni, Thao Le, Jessica Safier, Kevin Delucchi, and Joseph Guydish. "Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds." Journal of Substance Abuse Treatment 135 (April 2022): 108640. http://dx.doi.org/10.1016/j.jsat.2021.108640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Enyioha, Chineme, Graham W. Warren, Glen D. Morgan, and Adam O. Goldstein. "Tobacco Use and Treatment among Cancer Survivors." International Journal of Environmental Research and Public Health 17, no. 23 (December 6, 2020): 9109. http://dx.doi.org/10.3390/ijerph17239109.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Leone, Frank T., Sarah Evers-Casey, Benjamin A. Toll, and Anil Vachani. "Treatment of Tobacco Use in Lung Cancer." Chest 143, no. 5 (May 2013): e61S-e77S. http://dx.doi.org/10.1378/chest.12-2349.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Tobacco use Treatment Victoria"

1

Lindblom, Nina. "Novel pharmacological treatment alternatives for nicotine dependence /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-437-6/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Moody, Lara. "Reducing Substance Use with Implementation Intentions: A Treatment for Health Risk Behaviors." Diss., Virginia Tech, 2017. http://hdl.handle.net/10919/85569.

Full text
Abstract:
Maladaptive habits, such as substance use, that are highly ingrained and automatized behaviors with negative long-term health consequences need effective interventions to promote change towards more healthful behaviors. Implementation intentions, the structured linking of critical situations and alternative, healthier responses, have been shown to improve health-benefiting behaviors such as eating more fruits and vegetables and being more physically active (Sheeran, Milne, Webb, and Gollwitzer, 2005). Here, a laboratory analogue for smoking relapse and a pilot clinical trial of alcohol use are assessed using implementation intention interventions to reduce these health risk behaviors. In Study 1, heavy smokers completed a smoking resistance task that is a candidate analogue for smoking relapse. Participants were exposed to an in-laboratory implementation intention and/or monetary incentive condition during each of four experimental sessions. The combined implementation intention and monetary incentive condition resulted in the greatest delay to smoking initiation. In Study 2, individuals with alcohol use disorder completed an active or control implementation intention treatment condition. Remotely, both treatment groups received a daily ecological momentary intervention, thrice daily biologic breath alcohol ecological momentary assessments, and once daily self-report ecological momentary assessment of alcohol consumption during the intervention period. The active implementation intention group was associated with a greater reduction in alcohol consumption compared to the control group. Together, these studies provide experimental and initial clinical evidence for implementation intentions, in conjunction with other effective treatments (Study 1) and technological advancements (Study 2), to intervene on and reduce substance use. This project is the first to use implementation intentions in a laboratory evaluation of smoking resistance and in an initial clinical trial to reduce alcohol consumption in a naturalistic community sample using both ecological momentary assessments and ecological momentary interventions.
Ph. D.
APA, Harvard, Vancouver, ISO, and other styles
3

Farietta, Thalia Paola. "Tobacco Use and Cessation Practices in Three Appalachian Ohio Behavioral Health Clinics." The Ohio State University, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=osu150265645941645.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Morger, Joseph E. "An Exploration of Smoking Abstinence Expectancies Among Individuals in Substance Abuse Treatment." Xavier University / OhioLINK, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=xavier1525795092891739.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chan, Kin-keung, and 陳健強. "Expanding the role of social workers in the treatment of tobacco-dependency in the elderly: a demonstrationproject." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B31971477.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

馮美儀. "耳穴戒烟之認識調查." HKBU Institutional Repository, 2006. http://repository.hkbu.edu.hk/etd_ra/735.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

叢珮琪 and Pui-kee Peggy Tsung. "Nurses' role in smoking cessation: knowledge,attitudes and behaviours." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2002. http://hub.hku.hk/bib/B26294825.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ismael, Silvia Maria Cury. "Efetividade da terapia cognitivo-comportamental na terapêutica do tabagista." Universidade de São Paulo, 2007. http://www.teses.usp.br/teses/disponiveis/5/5160/tde-21062007-113413/.

Full text
Abstract:
O tabagismo tem sido considerado um problema de saúde pública mundial pela Organização Mundial da Saúde. São previstas, para 2020, mais de dez milhões de mortes no mundo por doenças tabaco-relacionadas. Torna-se, portanto, importante aprimorar formas de tratamento aos fumantes que queiram parar de fumar e busquem ajuda por não se sentirem capazes de conseguí-lo sozinhos. O objetivo da presente proposta foi investigar se a efetividade de um programa de tratamento com base na terapia cognitivo-comportamental, associada à medicação, seria mais efetivo do que a literatura reporta para a abstinência/recaída. O critério de efetividade foi a cessação do tabagismo auto-referida pelos participantes em seis meses de tratamento. Foram avaliados 61 fumantes, com idades variando entre 18 a 60 anos, de ambos os sexos. Estes fumantes foram divididos em três grupos: pacientes que não pararam de fumar (grupo 1 ), abstinentes (grupo 2) e que recaíram (grupo 3). Os resultados demonstraram que, desta população, 78,7% estavam abstinentes ao final de seis meses de tratamento. Antes, eles fumavam, em média, por 24,6 anos, 22,6 cigarros por dia; 62,3% estavam no estágio de contemplação de acordo com Prochaska. Os motivos mais freqüentes citados para a recaída foram estresse (61,9%) e ansiedade (19%). A média geral do Fagerström foi de 4,18 (tolerância baixa), sendo que o grupo 1 apresentou o grau de tolerância menor da amostra. 77,4% dos fumantes manifestaram estar satisfeitos com o tratamento, sendo que os motivos maiores de satisfação foram o apoio psicológico e a interação com o grupo. O índice de Saúde Geral da amostra é compatível com a população geral; o Inventário Beck de Depressão (BDI) mostrou níveis maiores de depressão nos grupos 1 e 3. Foram propostos indicadores de maior risco de recaída: número de anos que o participante fuma (maior), número de cigarros fumados por dia (menor), ter fumado sempre a mesma quantidade de cigarros por dia, morar com outros fumantes, teores baixos de nicotina no cigarro em relação ao médio e alto, ausência de tentativas anteriores para cessar de fumar, freqüência baixa de participação nas sessões de tratamento, utilizar o cigarro como estimulante, fumar quando entusiasmado, quando não consegue permanecer em locais onde o fumo é proibido, quando refere ter dó de si próprio, quando manifesta pouca satisfação em relação ao trabalho e à vida. A Curva de sobrevida de Kaplan-Meier demonstrou que 49,7% desta amostra devem permanecer em abstinência por um ano, índice maior do que reporta a literatura revisada. Propõe-se a realização de estudo randomizado, com uma população maior, para validar os indicadores propostos e a efetividade comparativa do programa.
Tobaccoism has been considered as a World Public Health problem according to the World Health Organization. More than 10 million deaths in the world caused by problems related to tobacco is the prevision for 2020. Therefore, it is important to improve ways of treatment for smokers who would like to quit smoking and search for help for not being able to do so by themselves. The purpose of this present proposal was to check whether the effectiveness of a treatment based on Cognitive-Behavior Therapy associated with medication was better than the literature reported to abstinence/relapse. The effectiveness criterion was the self- mentioned smoking cessation by the participants in 6 months of the treatment. 61 smokers aged 18-60 years both male and female were evaluated. These smokers were divided into three groups: patients who did not give up smoking (group 1), the abstinence smokers (group 2) and the relapse ones (group 3). The results showed that by the end of 6 months of treatment 78,7% of this population had become abstainers. At first, as an average they smoked for 24,6 years, 22,6 cigarettes a day; 62,3% was on contemplation stage according to Prochaska. The most frequent mentioned causes for the relapse were stress (61,9%) and anxiety (19%). Fagerström general average was 4,18 (low tolerance) so that group 1 showed a lower degree of tolerance of the sample. 77,4% of the smokers mentioned to be happy with the treatment due to the psychological support and group interaction as main reasons. The General Health Index of the sample is compatible with general population and the Beck Depression Inventory (BDI) showed higher levels of depression in groups 1 and 3. Indicators of higher relapse risk were suggested: the participant smoking time (higher), how many cigarettes a day (lower), having always smoked the same quantity of cigarettes a day, living with another smokers, low nicotine in the cigarette in relation to the medium and high ones, absence of previous attempts to stop smoking, low frequency of participation in the meetings for treatment, using the cigarette as a stimulant, smoking when the smoker is excited, when he can\'t help remaining where smoking is forbidden, when the smoker mention to be sorry for himself, when the smoker presents no pleasure in relation to work and life. The Kaplan-Meier survival curve showed that 49,7% of this sample must continue in abstinence for one year, a higher index than the reported revised literature. It is suggested to perform randomized studies, with a bigger population, to validate the appointed indicators and the comparative effectiveness of the program.
APA, Harvard, Vancouver, ISO, and other styles
9

Dovorogwa, Hamlton. "The potential use of tobacco waste for the passive treatment of acid mine drainage." Thesis, 2020. https://hdl.handle.net/10539/31188.

Full text
Abstract:
School of Civil and Environmental Engineering, Faculty of Engineering and the Built Environment, University of the Witwatersrand, 2020
Tobacco waste (dust and stem) was successfully used as a metal cation adsorbent, pH modifier and carbon/energy source for sulfate reducing bacteria during acid mine drainage (AMD) biotreatment. Firstly, the compositional analysis for both tobacco waste and the AMD were conducted. Batch adsorption and bioremediation tests were then run using the synthetic and gold mining tailing dump-based AMD wastewater. The industrial AMD assayed in (Fe2+-420.23),(Ni2+-20.32), (Cu2+-38.21), (Zn2+-5.73) and (SO42-3318.23) all in mg/L. Adsorption tests lasted 15 hours, while bioremediation incubation periods were 50 days. For the bioremediation, sulfate reducing bacteria were inoculated into the AMD effluent after growing for some time in a nutrient enriched growth media. Different adsorbent loadings of 20-, 40-, 80- and 160g/L were tested for adsorption and while 80 g/L was chosen for bioremediation trials. Tobacco waste performance as metal cation adsorbent, AMD pH modifier and energy source for SRBs was monitored by recording metals removal efficiencies, sulfate reduction, pH trends and dissolved COD in the AMD effluent during the trials. Metal removals during adsorption were found to be at maximum of 38-, 41-, 31-and 43% for iron, nickel, copper and zinc respectively. These results were for 80g/L adsorbent (tobacco waste) loadings. At different loadings, the overall metal removals were lowest for the lowest adsorbent loading of 20g/L and highest for the highest loading of 160g/L. The increase in metal removals as adsorbent loading increase were significant between 20g/Land 80g/L, and increasing the adsorbent loading further to 160g/L did not introduce a proportional increase in metal removals, hence no further increases in adsorbent loading were investigated. The Langmuir adsorption isotherm best fitted the iron data while the Sips adsorption isotherm described well the adsorption of nickel, copper and zinc onto tobacco waste. Introducing SRBs in the bioremediation scheme increased the metals removal as well as the sulfate reduction into sulfides and sulfur. The pH of the AMD also increased and a few carbonates and hydroxides also precipitated out. Maximum metal removals in SRB mediated remediation were 95-, 97-, 70-and 93% for iron, nickel, copper and zinc respectively. Copper demonstrated the highest recalcitrance to both adsorption and bioremediation. Sulfate removal reached 63% in synthetic AMD while it was slightly higher at 67% in industrial AMD. The final AMD pH after the SRB mediated bioremediation went up by 2.05 units starting from a value of 2.7 (industrial) and 3 (synthetic).The metals and sulfate concentration remaining in AMD during AMD treatment can be modelled using the exponential decay function. Overall, the tobacco waste proved to have a high potential both as adsorbent and as carbon source for sulfate reducing bacteria that facilitate AMD biological treatment
CK2021
APA, Harvard, Vancouver, ISO, and other styles
10

Tremain, Danika Lea. "Increasing the provision of preventive care by clinicians within substance use treatment settings." Thesis, 2019. http://hdl.handle.net/1959.13/1404535.

Full text
Abstract:
Research Doctorate - Doctor of Philosophy (PhD)
People with substance use problems have significantly higher mortality and morbidity rates and reduced life expectancy compared to the general population. Part of this excess mortality and morbidity is attributable to substance use, however a significant proportion is due to higher rates of other preventable chronic illness. A high prevalence of additional modifiable health risk behaviours, specifically tobacco smoking, insufficient fruit and/or vegetable consumption and insufficient physical activity, contributes to such chronic disease levels. Substance use treatment settings are an opportunity for the delivery of preventive care to address modifiable health risk behaviours for people who have substance use problems. Despite this opportunity, relatively little is known about health risks behaviours and preventive care for people attending substance use treatment. Only very limited research has examined the prevalence of health risk behaviours for people with substance use problems; the provision of preventive care by substance use treatment clinicians; and clinical practice change strategies that may be effective in increasing the provision of such care within substance use treatment settings. To address this gap in the knowledge, the broad aims of this thesis were to: 1. Identify the prevalence of three chronic disease health risk behaviours (tobacco smoking, insufficient fruit and vegetable consumption, and insufficient physical activity) among clients of community substance use treatment services. 2. Examine the prevalence of preventive care provision (in the form of assessment, brief advice and referral) for such health risk behaviours in community substance use treatment settings. 3. Explore the potential association between clinician attitudes and beliefs with the provision of preventive care for such health risk behaviours. 4. Determine the effectiveness of a clinical practice change intervention in increasing community substance use treatment clinicians’ provision of preventive care (in the form of assessment, brief advice and referral) for three health risk behaviours (tobacco smoking, insufficient fruit and vegetable consumption, and insufficient physical activity) within community substance use treatment services. To address the above aims, a series of studies was undertaken from 2012 to 2014 within 15 community substance use treatment services in one local health district in New South Wales, Australia. These studies included: a cross-sectional survey of 386 community substance use treatment clients; a cross-sectional survey of 54 community substance use treatment clinicians; and a pre-post multi-strategic clinical practice change pilot intervention trial. The studies were evaluated utilising surveys of clients attending community substance use treatment services over a two-year period and surveys of community substance use treatment clinicians. In addition, a systematic review of the peer-reviewed literature that describes the prevalence of preventive care delivery in substance use setting was undertaken. This thesis contributes significantly to the limited research in this area in several ways. Firstly, this thesis reported a high prevalence of modifiable health risk behaviours (tobacco smoking, insufficient fruit and/or vegetable consumption, insufficient physical activity) in community substance use treatment clients and high client interest in modifying such behaviours. In addition, both community substance use treatment clinicians and clients reported favourable attitudes towards the provision of preventive care within substance use treatment settings. However, the provision of preventive care to address such behaviours was found to be suboptimal for all care elements (assess, advise, refer) for insufficient fruit and/or vegetable consumption and insufficient physical activity and referral for all health risk behaviours. The systematic review, although limited to tobacco smoking care, supported this finding. The review also highlighted a variety of measures currently utilised to record and report the provision of preventive care in substance use treatment settings. Secondly, the multi-strategic clinical practice change intervention that aimed to increase the provision of preventive care in substance use treatment settings had varying impact across elements of care and risk factors. Although an increase in the provision of care for insufficient fruit and/or vegetable consumption was indicated, the intervention had no impact on care for smoking and insufficient physical activity. This thesis identified a need for further research regarding the provision of preventive care for multiple health risk behaviours in substance use treatment settings. It is suggested that future research consider: how the provision of preventive care in substance use treatment settings is measured; the barriers and facilitators to the provision of preventive care; and the use of robust study designs when examining the effectiveness of interventions that aim to increase clinician provision of preventive care.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Tobacco use Treatment Victoria"

1

Gold, Mark S. Tobacco. New York: Plenum Medical Book Co., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Severson, Herbert H. Enough snuff: A guide to quitting smokeless tobacco. 7th ed. Eugene, OR: Applied Behavior Science Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Anderson, D. Michael. School-based opportunities for tobacco use intervention. Bethesda, Md: National Heart, Lung, and Blood Institute, Office of Prevention, Education, and Control, Smoking Education Program, National Institutes of Health, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Anderson, D. Michael. School-based opportunities for tobacco use intervention. Bethesda, Md: National Heart, Lung, and Blood Institute, Office of Prevention, Education, and Control, Smoking Education Program, National Institutes of Health, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Anderson, D. Michael. School-based opportunities for tobacco use intervention. Bethesda, Md: National Heart, Lung, and Blood Institute, Office of Prevention, Education, and Control, Smoking Education Program, National Institutes of Health, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Anderson, D. Michael. School-based opportunities for tobacco use intervention. Bethesda, Md: National Heart, Lung, and Blood Institute, Office of Prevention, Education, and Control, Smoking Education Program, National Institutes of Health, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Anderson, D. Michael. School-based opportunities for tobacco use intervention. Bethesda, Md: National Heart, Lung, and Blood Institute, Office of Prevention, Education, and Control, Smoking Education Program, National Institutes of Health, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Anderson, D. Michael. School-based opportunities for tobacco use intervention. Bethesda, Md: National Heart, Lung, and Blood Institute, Office of Prevention, Education, and Control, Smoking Education Program, National Institutes of Health, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Michael, Fiore, and United States. Tobacco Use and Dependence Guideline Panel., eds. Treating tobacco use and dependence. [Rockville, Md.]: U.S. Dept. of Health and Human Services, Public Health Service, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nicotine dependence: Understanding and applying the most effective treatment interventions. Washington, DC: American Psychological Association, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Tobacco use Treatment Victoria"

1

Drobes, David J. "Pharmacological treatment of tobacco use disorder." In APA handbook of psychopharmacology., 609–29. Washington: American Psychological Association, 2019. http://dx.doi.org/10.1037/0000133-027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Xin, Yu. "Comments Regarding Epidemiology of Tobacco Use, Tobacco Use: Prevention and Tobacco Abuse: Treatment and Management." In Substance Abuse Disorders, 293–95. Chichester, UK: John Wiley & Sons, Ltd, 2011. http://dx.doi.org/10.1002/9780470975084.ch27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Carrillo, Noel. "Nicotine Dependence and Tobacco Use Disorder Treatment." In Psychiatry Update, 101–11. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-86430-9_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Assanangkornchai, Sawitri, and J. Guy Edwards. "Clinical Screening for Illegal Drug Use, Prescription Drug Misuse and Tobacco Use." In Textbook of Addiction Treatment, 619–35. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-36391-8_43.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Schmidt-Owens, Mary. "Screening and intervention for tobacco use." In Screening, brief intervention, and referral to treatment for substance use: A practitioner's guide., 51–65. Washington: American Psychological Association, 2020. http://dx.doi.org/10.1037/0000199-004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jackson, Kristina M., Kenneth J. Sher, and John E. Schulenberg. "Conjoint developmental trajectories of young adult alcohol and tobacco use." In Addictive behaviors: New readings on etiology, prevention, and treatment., 225–56. Washington: American Psychological Association, 2009. http://dx.doi.org/10.1037/11855-010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Salam, Shumona Sharmin, and Caroline Mitchell. "Evaluating Alcohol, Tobacco, and Other Substance Use in Pregnant Women." In Evidence Based Global Health Manual for Preterm Birth Risk Assessment, 53–62. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-04462-5_7.

Full text
Abstract:
AbstractUse of tobacco, alcohol, and psychoactive substances during pregnancy is associated with increased risks of preterm birth. Concurrent use of these substances is also quite common and further increases the risk of adverse outcomes. Health-care providers should ask pregnant women about their exposure to tobacco, second-hand smoke, alcohol, and illicit substances (past and present) at every antenatal visit using validated screening instruments and offer brief interventions.Pregnant women with alcohol or substance dependence should be assessed individually and offered psychosocial interventions (e.g. motivational interviewing, cognitive behavioural therapy, contingency management). Pregnant women should be advised to quit and referred to detoxification services or opioid substitution treatment (for opioid users). Pharmacological treatment for maintenance and relapse prevention is not recommended for amphetamine, cannabis, and cocaine dependence and requires individual risk-benefit analysis for alcohol dependence. Opioid maintenance therapy with methadone or buprenorphine is recommended for opiate dependence. Pregnant women who are current tobacco users or have recently quit should be offered psychosocial interventions (e.g. counselling, incentives, social support). Evidence on impact of pharmacological interventions for cessation of tobacco use is limited. Interventions to make public places and homes smoke-free are recommended. Evidence of impact of these interventions in reducing PTB especially in LMIC settings is low and further research recommended.
APA, Harvard, Vancouver, ISO, and other styles
8

Kalman, David, Rashelle Hayes, and Douglas Ziedonis. "Tobacco Use Disorder." In The American Psychiatric Publishing Textbook of Substance Abuse Treatment. American Psychiatric Publishing, 2014. http://dx.doi.org/10.1176/appi.books.9781615370030.mg16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

"Tobacco Use Disorders." In Substance and Nonsubstance Related Addiction Disorder: Diagnosis and Treatment, edited by Frederick Petty, James Meyer, and Vidhyalakshmi Selvaraj, 203–15. BENTHAM SCIENCE PUBLISHERS, 2017. http://dx.doi.org/10.2174/9781681083438117010021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Fucito, Lisa M., and Stephen R. Baldassarri. "Tobacco Use Disorder and Treatment." In Lung Cancer: A Practical Approach to Evidence-Based Clinical Evaluation and Management, 183–96. Elsevier, 2018. http://dx.doi.org/10.1016/b978-0-323-48565-4.00012-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Tobacco use Treatment Victoria"

1

Principe, Rosastella, Biagio Tinghino, Vincenzo Zagà, Salvatore Cardellicchio, Licia Siracusano, Giovanni Zelano, and Maria Sofia Cattaruzza. "Use of cytisine for smoking cessation in Italian Centers for Tobacco Treatment." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa4476.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Shorstkii, I. A., and N. N. Vinevskaia. "PROSPECTS FOR THE USE OF MICROPLASMA TREATMENT OF TOBACCO LEAVES FOR FURTHER PROCESSING." In Состояние и перспективы мировых научных исследований по табаку, табачным изделиям и инновационной никотинсодержащей продукции. Краснодар: Государственное научное учреждение Всероссийский научно-исследовательский институт табака, махорки и табачных изделий Российской академии сельскохозяйственных наук, 2020. http://dx.doi.org/10.48113/496_2020_193-197.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

El Hajj, Maguy, Ahmed Awaisu, Nadir Kheir, Mohamad Haniki, Rula Shami, Rana Saleh, Noora AlHamad, Ahmad Almulla, and Ziyad Mahfoud. "Evaluation of an Intensive Education Program on the Treatment of Tobacco-use Disorder for Pharmacists: A Randomized Controlled Trial." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0112.

Full text
Abstract:
Tobacco use is one of the main causes of premature deaths and preventable diseases in Qatar. The aim of this randomized controlled trial (RCT) is to design, implement, and evaluate an intensive education program on tobacco-use treatment for pharmacists in Qatar. The study objectives are to assess the effectiveness of the program on pharmacists’ knowledge, skills, attitudes and perceived self-efficacy toward tobacco cessation. Methods: Community pharmacists practicing in Qatar were eligible for participation in the study. Consenting participants were randomly allocated to intervention or control groups. Participants in the intervention group received an intensive education program on treatment of tobacco-use disorder. A short didactic session on a non-tobacco-related topic was delivered to pharmacists in the control group. Outcomes were assessed using survey instruments. Results: Participants in the intervention group (n=57) achieved significantly higher total tobacco-related knowledge scores (mean=33 points) than those in the control group (n=37) (mean=24.5 points) with a p-value of <0.001. Post-intervention total knowledge scores were significantly higher than the baseline scores for participants who received intensive tobacco education with a mean difference of 6.6 points (p-value <0.001). Overall attitudes toward tobacco cessation and self-efficacy in tobacco cessation interventions were better in the group of pharmacists who received tobacco education compared to those who did not. For instance, 43.4% of pharmacists in the intervention group “strongly agreed” that their counseling will increase a patient’s likelihood of quitting tobacco use compared to 14.7% in the control group (p-value=0.014). Furthermore, 20.4% of pharmacists in the intervention group reported that they are “extremely confident” to use appropriate questions to ask patients when providing tobacco cessation counseling versus 5.9% in the control group (p-value=0.005). Conclusion: The findings of this study suggest that provision of an intensive educational program on the treatment of tobacco use disorders results in improved tobacco-related knowledge and self-efficacy in tobacco cessation interventions.
APA, Harvard, Vancouver, ISO, and other styles
4

El Hajj, Maguy, Ahmed Awaisu, Nadir Kheir, Mohamad Haniki, Rula Shami, Rana Saleh, Noora AlHamad, Ahmed Almulla, and Ziyad Mahfoud. "Assessment of an Intensive Education Program on the Treatment of Tobacco-Use Disorder for Pharmacists using OSCE (Objective Structured Clinical Examination)." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0113.

Full text
Abstract:
Tobacco use is one of the main causes of morbidity and mortality in Qatar. The aim of this randomized controlled trial (RCT) is to design, implement, and evaluate an intensive education program on tobacco-use treatment for pharmacists in Qatar. The study objectives are to assess the effectiveness of the program on pharmacists’ skills toward tobacco cessation. Methods: A random sample of community pharmacists in Qatar was selected for participation. Consenting participants were randomly allocated to intervention or control groups. Participants in the intervention group received an intensive education program on treatment of tobacco-use disorder. A short didactic session on a non-tobacco-related topic was delivered to pharmacists in the control group. The pharmacists’ tobacco cessation skills were assessed using an Objective Structured Clinical Examination (OSCE). Six-station OSCE targeting core smoking cessation competencies and skills was completed by participants in both groups. Performance of participants was assessed using validated assessment checklists that comprised analytical and global assessment sections. Results: A total of 54 and 32 participants in the intervention and the control group respectively completed the OSCE. Overall, pharmacists in the intervention group performed better in the analytical and global assessment sections than those in the control group. For example, for case 1, mean scores for developing rapport, data gathering and management were 2.76 vs 0.97 (p-<0.001), 5 vs 2.81 (p <0.001), and 3.5 vs 2.25 (p=0.001) respectively for the intervention group compared to the control group. Mean total analytical scores were 12.06 vs 6.4 (p-<0.001) for intervention compared to the control group for case 1. Furthermore, mean global assessment scores for case 1 were 3.19 vs 2.41 (p=0.009) for the intervention compared to the control group. Conclusion: The study results suggest that provision of an intensive educational program on the treatment of tobacco use results in improved skills toward tobacco cessation.
APA, Harvard, Vancouver, ISO, and other styles
5

Fitzke, Reagan, Jordan Davis, and Eric Pedersen. "Co-use of Tobacco/Nicotine and Cannabis Among Veterans: A Preliminary Investigation of Prevalence and Associations with Mental Health Outcomes." In 2020 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2021. http://dx.doi.org/10.26828/cannabis.2021.01.000.10.

Full text
Abstract:
While tobacco and cannabis use rates remain high in the general U.S. population, veterans from the conflicts in Iraq and Afghanistan (i.e., OEF/OIF veterans) are at particularly high risk of high rates of cannabis and tobacco use. Co-use of tobacco/nicotine and cannabis (i.e., using both substances within a specified period of time or combining the drugs within the same device for use) is of growing prevalence in the United States. Tobacco/nicotine and cannabis use is often associated with poor mental health outcomes such as stress, anxiety, and depression. However, little is understood about the prevalence rates of tobacco/nicotine and cannabis co-use among U.S. veterans as well as associations with mental health symptomology. The current study aimed to investigate types of tobacco/nicotine and cannabis co-use among veterans, as well as associations between co-use and mental health outcomes of stress, depression, anxiety, and posttraumatic stress disorder. Participants (N= 1,548) were recruited through social media websites and completed an online survey as part of a larger study. The majority (80%) endorsed tobacco/nicotine and/or cannabis use in the past 30 days. Descriptive analyses were run to assess prevalence of use within the sample. Mean comparisons were conducted to assess differences in past 30-day frequency of use and for mental health outcomes between co-users and single users of either substance. Among the larger sample, 90% endorsed lifetime use of tobacco/nicotine, 23% endorsed lifetime use of cannabis, and 21% endorsed any lifetime co-use of both substances. These participants also endorsed past 30 day use of tobacco/nicotine (77%), cannabis (10%), and co-use (7%). Among the past 30-day cannabis users, 66% reported also using tobacco/nicotine, while 9% of past 30-day tobacco/nicotine users also reported cannabis use. When comparing cannabis-only users to co-users of cannabis and tobacco/nicotine, anxiety symptoms were reported as significantly higher among co-users. Tobacco/nicotine-only users endorsed higher past 30-day frequency of cigarettes and e-cigarettes compared to co-users; however, co-users endorsed significantly higher levels of stress and symptoms of PTSD, depression, and anxiety compared to tobacco/nicotine-only users. Results suggest that the addition of cannabis use in conjunction with tobacco/nicotine use may be associated with greater mental health symptoms among veterans. Findings have implications for future veteran mental health care and substance use treatment among tobacco/nicotine and cannabis co-users.
APA, Harvard, Vancouver, ISO, and other styles
6

Hart, J., T. Klaiman, A. Belk, J. Kim, J. Silvestri, S. Szymanski, D. Sheu, and S. D. Halpern. "Use of Mobile Health Tools to Facilitate Tobacco Treatment Among Older, Underserved Adults: A Community-Based Approach to Intervention Refinement." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a1341.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wyatt, Riley, Amy Cohn, and Sarah Ehlke. "Exploring sensation-seeking and first cannabis use experiences as correlates of current cannabis use problems in young adult cannabis and tobacco co-users." In 2021 Virtual Scientific Meeting of the Research Society on Marijuana. Research Society on Marijuana, 2022. http://dx.doi.org/10.26828/cannabis.2022.01.000.48.

Full text
Abstract:
Introduction: Current cannabis use is high in young adults (ages 18-24) and cannabis use disorder (CUD) rates have increased over the last decade. Subjective responses to one’s first use of cannabis may explain continued use, wherein more positive first use experiences influence progression to regular and problematic use. Sensation seeking is associated with cannabis use and may also influence cannabis problem severity. This study examined the relationship between subjective experiences at first cannabis use and sensation seeking on cannabis use behavior and CUD diagnosis. Method: Participants were 97 young adult current cannabis and tobacco co- users (55.7% male, 50.5% White) who completed the baseline survey of a longitudinal study examining daily patterns of tobacco and cannabis use and co-use. Participants completed the 4-item Brief Sensation Seeking Scale and indicated intensity of 15 sensations at first cannabis use (1 = not at all to 5 = intense): dizziness, lightheadedness, nausea, paranoia, confusion, happiness, anxiety, taste, smell, relaxation, energy, difficulty inhaling, coughing or choking, giddiness or laughter, and rush or “buzz.” Cannabis use outcomes included: (1) past 30-day number of days used cannabis; (2) past 30-day cannabis intoxication intensity (1 = not at all high to 10 = extremely high); and (3) likelihood of a CUD (score ≥ 12 on the Cannabis Use Disorder Identification Test- Revised). Analyses: A principal components analysis (PCA) reduced the 15 sensations into factors. Next, separate regression analyses (linear or binary logistic) were conducted to examine the associations of the PCA-derived factors and sensation seeking on the cannabis outcomes, controlling for gender, race, and age at first cannabis use. Results: Over half (61.9%) of the participants met criteria for a CUD. PCA results indicated a 4-factor solution: (1) “positive emotional experiences” (e.g., happy); (2) “negative physical experiences” (e.g., dizzy); (3) “negative emotional experiences” (e.g., paranoia); and (4) “taste and smell.” Regression results indicated greater negative physical experiences were associated with an increased likelihood of a CUD diagnosis (AOR = 1.93, p = .038) and lower average cannabis intoxication (b = -0.343, p = .049). Greater negative emotional experiences at first use were associated with less frequent cannabis use in the past 30 days (b = -2.043, p = .028). Conclusion: Negative emotional experiences associated with first use of cannabis may impede continued use. Negative physical experiences (e.g. nausea, lightheadedness) may be variable in perception, which could explain the inconsistent associations of this factor with CUD diagnosis and past 30-day use. Understanding subjective experiences of first cannabis use could be used as a treatment target by helping patients identify reinforcing sensations associated with their use, and guiding them to sober activities with similar sensations.
APA, Harvard, Vancouver, ISO, and other styles
8

"SUBSTANCE USE AND PSYCHOPATHOLOGY IN THE PSYCHIATRIC CARE UNIT OF THE SOCIAL AFFAIRS SERVICE OF THE UNIVERSITY OF SALAMANCA." In 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021p030v.

Full text
Abstract:
Introduction: University stage imply some changes and challenges that turn it into a crucial and tricky period for mental health and substance use. Material and methods: We present a study based on a sample of 49 people of the university community, 37 women and 12 men, evaluated in a seven months period. The assessment consisted in an interview carried out by a psychiatrist. A database was designed, providing the clinical information obtained from the interview and entry sheets during the first visit. Following descriptive and analytic studies were performed using the hypothesis contrast “Chi-Square” test. The reference statistical significance level was α = 0.05. Aims: To study the impact of substance use in the mental health of our sample in order to implement new prevention and treatment strategies. Results: 53,1% of the sample abuse substances: 30,8% men and 69,2% women (p 0,277). Alcohol is the most used substance in the sample (80,8%), followed by tobacco (57,7%) and cannabis (30,8%). Concerning psychopathology, insomnia (53,8%) is the most frequent symptom (p 0,260); thoughts of death were present in 46,2% of the substance users (p 0,419); while self-harm (p 0,365) and suicidal attempts (p 0,113) were described by the 19,2% of that group of the sample. Eating disorders and psychosis were observed in 23,1% (p 0,560) and 11,5% (p 0,743) respectively. Conclusions: Substance use is a very prevalent practice in our sample. We have observed some clinical symptoms are frequent in this part of the sample and we should pay special attention to their prevention and early treatment, as well as that of the substance use. This way we could minimize and tackle Mental Health problems in our sample.
APA, Harvard, Vancouver, ISO, and other styles
9

"EPIDEMIOLOGICAL CHARACTERISTICS OF A SAMPLE OF PATIENTS WITH SUBSTANCE USE FROM THE PSYCHIATRIC CARE UNIT OF THE SOCIAL AFFAIRS SERVICE OF THE UNIVERSITY OF SALAMANCA." In 23° Congreso de la Sociedad Española de Patología Dual (SEPD) 2021. SEPD, 2021. http://dx.doi.org/10.17579/sepd2021p019v.

Full text
Abstract:
Introduction: University life presents changes and challenges that may affect the mental health of its community and be the onset of substance use. Aim: To study epidemiological characteristics in our sample to help to improve prevention and treatment for mental health problems related to substance use. Materials and Methods: The descriptive study is based on a sample of 49 people, 37 women and 12 men, members of the university community. A database was designed with clinical information about psychiatric patients obtained from the interview and entry sheets during the first visit. Results: 53,1% of the sample confirmed substance use. The mean age of patients was 22,35 years and 69,2% of them were women and 30,8% were men. Alcohol was the main used substance (80,8%), followed by tobacco (57,7%) and cannabis (30,8%). Most patients were from other provinces of Spain different from Salamanca (57,7%). Law and Social Sciences (38,5%) and Health Sciences (26,9%) were the most frequent academic fields. The main contact method was self-consultation (76,9%) and in most cases (46,2%) the reason of the consultation was not specific. After the interview, the main diagnosis impressions were major depressive disorder (19,2%), anxiety disorder (15,3%) and prodromal symptoms of psychosis (15,4%). Most of the patients were treated with a combination of medication and psychotherapy (42,3%). Conclusion: We should consider the possible impact of substance use in our patient’s mental health and take account of it when choosing their treatment. We should continue studying epidemiological characteristics to help to improve prevention measures and treatments in the future.
APA, Harvard, Vancouver, ISO, and other styles
10

Gomes Filho, José Euderaldo Costa, Ariane Silva da Rocha, Gisele Aparecida Fernandes, Rossana Verónica Mendoza López, and Maria Paula Curado. "SOCIODEMOGRAPHIC AND LIFESTYLE ASPECTS VERSUS ACCESS TO TREATMENT FOR PATIENTS WITH BREAST CANCER AT A CANCER CENTER IN SÃO PAULO." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2041.

Full text
Abstract:
Sociodemographic and lifestyle aspects versus access to breast cancer treatment — Single Health System (SHS) and Supplementary Health — were evaluated in a prospective cohort of patients with breast cancer. This is a cross-sectional study with 705 patients. As compared with sociodemographic characteristics, 56.5% (n=398) of the patients were seen through Supplementary Health, and for both SHS and Supplementary Health patients, there is a higher frequency of women aged above 50 years, with 62.2% (n=191) and 51% (n=203) (p=0.002); married, 48.2% (n=148) and 66.6% (n=265) (p <0.001); white, 69.4% (n=213) and 82.1% (n=325) (p<0.001); and for the level of education, 37.1% (n=114) of those with SHS had completed high school and 55.7% (n=221) (p<0.001) of those with Supplementary Health had completed college. The first mammogram occurred between the ages of 18 and 40 years, 72.5% (n=206) of the SHS participants and 88.6% (n=342) (p<0.001) for Supplementary Health; own housing for 90.6% (n=278) and 89.4% (n=354) (p<0.001); denied tobacco use, 65.5% (n=201) and 74.7% (n=296) (p=0.005); and alcohol consumption, 87.6% (n=269) and 77.2% (n=305) (p<0.001). However, there was no difference regarding previous diagnosis of breast cancer in 55.3% (n=114) and 64% (n=178) (p<0.001) and the type of care; eutrophic body mass index was 38.4% (n=118) and 42.1% (n=167) (p=0.079), respectively. Access to SHS and supplementary health care, age above 50 years, married, white, level of education, age at first mammogram, home ownership, smoking habits, and consumption of alcoholic beverages were significantly different; BMI was not different in the two groups. Therefore, the lifestyle of SHS and Supplementary Health patients was statistically different in this cohort of patients.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Tobacco use Treatment Victoria' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography